JAMA Oncology Acceptance Rate
JAMA Oncology does not publish a strong official acceptance rate. The better submission question is whether the study delivers practice-changing clinical oncology evidence at a population level.
Senior Researcher, Oncology & Cell Biology
Author context
Specializes in manuscript preparation and peer review strategy for oncology and cell biology, with deep experience evaluating submissions to Nature Medicine, JCO, Cancer Cell, and Cell-family journals.
Journal evaluation
Want the full journal picture?
See scope, selectivity, submission context, and what editors actually want before you decide whether the journal is realistic.
Quick answer: there is no strong official JAMA Oncology acceptance-rate number you should treat as exact. Third-party estimates place it in the 8–13% range, with a reported median time to first decision of about 21 days. With a 2025 JCR impact factor of ~20.1, JAMA Oncology is among the most selective oncology journals — but the editorial bar is about practice-changing clinical evidence, not just study quality.
If the paper is a small translational study without clear clinical implications, the acceptance-rate estimates are not the real constraint. The clinical impact is.
What you can say honestly about the acceptance rate
The AMA does not publish a stable official acceptance rate for JAMA Oncology. Third-party aggregators report estimates in the 8–13% range. These are directionally useful — this is clearly a very selective oncology journal — but the exact figure varies by source and year.
What is more stable is the editorial context:
- JAMA Oncology is part of the JAMA Network, with the JAMA editorial standards and review process
- the journal publishes monthly and emphasizes clinical oncology with population-level evidence
- median time to first decision is reported around 21 days, which is fast for this tier
- clinical trials, meta-analyses, and large registry studies are prioritized
That clinical-evidence focus and JAMA-network editorial rigor define the real submission bar.
What the journal is really screening for
At triage, the editor is usually asking:
- does this study change how oncologists will treat, screen, or monitor cancer patients?
- is the evidence clinical-level — randomized trials, large cohorts, systematic reviews, or registry analyses?
- does the study design meet JAMA Network standards for statistical rigor and reporting?
- would the findings inform clinical guidelines or oncology practice?
Papers with large, well-designed clinical trials or population-level evidence will survive triage at much higher rates than small translational studies or single-center observations.
The better decision question
For JAMA Oncology, the useful question is:
Does this study provide clinical oncology evidence strong enough to change practice or inform guidelines?
If yes, the journal is a strong fit. If the paper is primarily translational, primarily basic science, or a small clinical study without population-level implications, the acceptance rate is not the constraint. The clinical evidence level is.
Where authors usually get this wrong
The common misses are:
- centering strategy around an estimated percentage instead of checking clinical evidence level
- submitting translational work without a strong clinical bridge (better suited for CCR or Cancer Research)
- presenting single-center data without population-level generalizability
- underestimating JAMA Network reporting and statistical standards
- ignoring JCO as the primary competitor for the same manuscript pool
Those are evidence-level and scope problems before they are rate problems.
What to use instead of a guessed percentage
If you are deciding whether to submit, these pages are more useful than an estimated rate:
- JAMA Oncology cover letter
- Journal of Clinical Oncology acceptance rate (ASCO flagship)
- Lancet Oncology acceptance rate
- Annals of Oncology acceptance rate (ESMO flagship)
Together, they tell you whether the paper has enough clinical weight, whether the editorial timeline is manageable, and whether a different clinical oncology venue would be a cleaner fit.
Practical verdict
The honest answer to "what is the JAMA Oncology acceptance rate?" is that the AMA does not publish one, and third-party estimates in the 8–13% range should be treated as approximate.
The useful answer is:
- yes, this is among the most selective oncology journals
- the ~21-day median decision time is well-documented and fast for this tier
- use practice-changing evidence, clinical-trial data, and JAMA reporting standards as the real filter instead
If you want help pressure-testing whether this manuscript meets the clinical evidence bar before upload, a free Manusights scan is the best next step.
Sources
- 1. JAMA Oncology, AMA/JAMA Network.
- 2. JAMA Oncology author instructions, JAMA Network.
- 3. Clarivate Journal Citation Reports, 2025 edition (IF ~20.1).
- 4. SCImago Journal & Country Rank: JAMA Oncology, Q1 ranking.
Reference library
Use the core publishing datasets alongside this guide
This article answers one part of the publishing decision. The reference library covers the recurring questions that usually come next: how selective journals are, how long review takes, and what the submission requirements look like across journals.
Dataset / reference guide
Peer Review Timelines by Journal
Reference-grade journal timeline data that authors, labs, and writing centers can cite when discussing realistic review timing.
Dataset / benchmark
Biomedical Journal Acceptance Rates
A field-organized acceptance-rate guide that works as a neutral benchmark when authors are deciding how selective to target.
Reference table
Journal Submission Specs
A high-utility submission table covering word limits, figure caps, reference limits, and formatting expectations.
Before you upload
Want the full journal picture?
Scope, selectivity, what editors want, common rejection reasons, and submission context, all in one place.
These pages attract evaluation intent more than upload-ready intent.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Supporting reads
Conversion step
Want the full journal picture?
These pages attract evaluation intent more than upload-ready intent.